TCM
IDXX icon

TimesSquare Capital Management’s Idexx Laboratories IDXX Stock Holding History

TimesSquare Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86.1M Sell
163,457
-306
-0.2% -$172K 1.27% 20
2026
Q1 		$92M Sell
163,763
-3,488
-2% -$2.24M 1.56% 13
2025
Q4 		$113M Sell
167,251
-25,687
-13% -$17.5M 1.7% 6
2025
Q3 		$123M Sell
192,938
-8,338
-4% -$5.06M 1.76% 6
2025
Q2 		$108M Buy
201,276
+3,530
+2% +$1.69M 1.56% 12
2025
Q1 		$83M Buy
197,746
+4,230
+2% +$1.84M 1.34% 19
2024
Q4 		$80M Buy
193,516
+46,857
+32% +$20.6M 1.17% 24
2024
Q3 		$74.1M Sell
146,659
-1,910
-1% -$928K 1.11% 26
2024
Q2 		$72.4M Sell
148,569
-1,650
-1% -$828K 1.14% 26
2024
Q1 		$81.1M Sell
150,219
-8,200
-5% -$4.48M 1.18% 23
2023
Q4 		$87.9M Sell
158,419
-31,755
-17% -$14.9M 1.29% 19
2023
Q3 		$83.2M Buy
190,174
+40,592
+27% +$20.2M 1.29% 15
2023
Q2 		$75.1M Buy
149,582
+46,987
+46% +$22.5M 1.08% 22
2023
Q1 		$51.3M Sell
102,595
-62,680
-38% -$30M 0.75% 51
2022
Q4 		$67.4M Buy
165,275
+33,575
+25% +$13M 0.96% 24
2022
Q3 		$42.9M Buy
131,700
+130,500
+10,875% +$47.9M 0.6% 71
2022
Q2 		$421K Buy
+1,200
New +$489K 0.01% 187

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

TimesSquare Capital Management's IDXX Position: Q2 2026 in Review

TimesSquare Capital Management reduced its Idexx Laboratories (IDXX) stake by 0.19% in Q2 2026, selling an estimated $172K and leaving 163,457 shares worth $86.1M. The position accounts for 1.27% of the portfolio, ranked #20.

TimesSquare Capital Management first reported a position in IDXX in Q2 2022 and has held it in 17 quarters since. The position peaked at $123M in Q3 2025. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • TimesSquare Capital Management held 163,457 shares of Idexx Laboratories worth $86.1M as of Q2 2026.
  • TimesSquare Capital Management sold 306 Idexx Laboratories shares in Q2 2026, an estimated $172K.
  • Idexx Laboratories made up 1.27% of TimesSquare Capital Management's portfolio in Q2 2026, its #20 holding.
  • TimesSquare Capital Management first reported a position in Idexx Laboratories in Q2 2022 and has held it in 17 quarters since.
  • TimesSquare Capital Management's Idexx Laboratories position peaked at $123M in Q3 2025.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on TimesSquare Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.